The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,007.50
Bid: 1,008.50
Ask: 1,009.00
Change: 9.70 (0.97%)
Spread: 0.50 (0.05%)
Open: 1,001.00
High: 1,010.50
Low: 999.20
Prev. Close: 997.80
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Nov 2023 12:56

RNS Number : 1286T
Smith & Nephew Plc
10 November 2023

SMITH & NEPHEW PLC

10 NOVEMBER 2023

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

VESTING OF RESTRICTED STOCK UNIT AWARDS GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022

In line with the announcement published on 3 May 2022, certain Restricted Stock Unit Awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") granted to Deepak Nath vested on 8 November 2023. These Restricted Stock Unit Awards formed part of the buy-out awards granted in respect of outstanding incentives Deepak Nath forfeited upon leaving his former company.

i. PARTIAL AND FINAL VESTING ON 8 NOVEMBER 2023 OF A RESTRICTED STOCK UNIT AWARD:

A Restricted Stock Unit Award of 8,716 shares was granted to Deepak Nath on 29 April 2022. One half of these shares (4,358 shares) vested on 8 November 2022 and the remaining half vested on 8 November 2023. A number of Shares were sold to cover taxation obligations arising on the vesting of the award.

The following relates to the individual included in the below notification in respect of the award that vested on 8 November 2023:

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial and final vesting of a Restricted Stock Unit Award granted on 29 April 2022 under the award agreement.

Date of Transaction

2023 - 11 - 08

Place of Transaction

London Stock Exchange (XLON)

Name

(Position)

Status

Price (£)

Volume

Aggregated information

Deepak Nath

(Chief Executive Officer)

Director

9.878

4,358 (of which 1,771 shares were sold to cover taxes due and 2,587 shares retained)

N/A Single Transaction

ii. PARTIAL VESTING ON 8 NOVEMBER 2023 OF A RESTRICTED STOCK UNIT AWARD:

A Restricted Stock Unit Award of 12,061 shares was granted to Deepak Nath on 29 April 2022. One quarter of these shares (3,015 shares) vested on 8 November 2022, a second quarter has vested on 8 November 2023, a third quarter will vest on 8 November 2024 and the final quarter will vest on 8 November 2025. A number of Shares were sold to cover taxation obligations arising on the vesting of the award.

The following relates to the individual included in the below notification in respect of the award that vested on 8 November 2023:

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc ordinary shares of USD 0.20 each

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting of a Restricted Stock Unit Award granted on 29 April 2022 under the award agreement.

Date of Transaction

2023 - 11 - 08

Place of Transaction

London Stock Exchange (XLON)

Name

(Position)

Status

Price (£)

Volume

Aggregated information

Deepak Nath

(Chief Executive Officer)

Director

9.878

3,015 (of which 1,225 shares were sold to cover taxes due and 1,790 shares retained)

N/A Single Transaction

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFEFLSLILIV
Date   Source Headline
9th Mar 20226:15 pmRNSTransaction in Own Shares
9th Mar 20226:01 pmRNSDirector/PDMR Shareholding
8th Mar 20226:14 pmRNSTransaction in Own Shares
8th Mar 20224:00 pmRNSDirector/PDMR Shareholding
7th Mar 20226:21 pmRNSTransaction in Own Shares
7th Mar 20223:30 pmRNSAnnual Financial Report
4th Mar 20226:07 pmRNSTransaction in Own Shares
4th Mar 202210:16 amRNSDirector/PDMR Shareholding
3rd Mar 20226:09 pmRNSTransaction in Own Shares
2nd Mar 20225:57 pmRNSTransaction in Own Shares
1st Mar 20226:12 pmRNSTransaction in Own Shares
1st Mar 202212:11 pmRNSTotal Voting Rights
28th Feb 20226:06 pmRNSTransaction in Own Shares
25th Feb 20226:05 pmRNSTransaction in Own Shares
24th Feb 20226:11 pmRNSTransaction in Own Shares
23rd Feb 20226:18 pmRNSTransaction in Own Shares
23rd Feb 20229:00 amRNSDirector/PDMR Shareholding
22nd Feb 202212:30 pmRNSTransaction in Own Shares
22nd Feb 20227:01 amRNSSmith+Nephew announces new Chief Executive Officer
22nd Feb 20227:00 amRNSFinal Results
1st Feb 20224:30 pmRNSBlock listing Interim Review
1st Feb 20221:15 pmRNSTotal Voting Rights
25th Jan 202210:00 amRNSJo Hallas joins Smith+Nephew as NED
25th Jan 20229:00 amRNSNotice of Results
19th Jan 20225:00 pmRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSS+N acquires novel cementless partial knee system
4th Jan 20221:12 pmRNSTotal Voting Rights
16th Dec 202112:00 pmRNSSmith+Nephew outlines ‘Strategy for Growth'
1st Dec 202112:08 pmRNSTotal Voting Rights
17th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 20214:30 pmRNSDirector/PDMR Shareholding
4th Nov 20217:00 amRNSTrading Statement
2nd Nov 202110:30 amRNSDirector/PDMR Shareholding
1st Nov 20213:00 pmRNSDirector/PDMR Shareholding
1st Nov 20211:53 pmRNSTotal Voting Rights
29th Oct 202111:45 amRNSDirector/PDMR Shareholding
22nd Oct 20219:00 amRNSSmith+Nephew to host Meet the Management event
15th Oct 20218:47 amRNSDividend Declaration
8th Oct 20219:00 amRNSNotice of Results
1st Oct 202110:16 amRNSTotal Voting Rights
24th Sep 20213:47 pmRNSDirector/PDMR Shareholding
17th Sep 20212:30 pmRNSAdditional Listing
16th Sep 20217:00 amRNSDirector/PDMR Shareholding
14th Sep 20215:00 pmRNSDirector/PDMR Shareholding
1st Sep 202110:59 amRNSTotal Voting Rights
27th Aug 20219:00 amRNSDirector/PDMR Shareholding
24th Aug 202110:30 amRNSDirector/PDMR Shareholding
23rd Aug 20211:00 pmRNSDirector/PDMR Shareholding
17th Aug 202111:15 amRNSDirector/PDMR Shareholding
4th Aug 202111:31 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.